Unlock instant, AI-driven research and patent intelligence for your innovation.
TCR primer group for specifically recognizing EBV peptide fragment with immune subtype of HLAA02 and application of TCR primer group
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A primer set, specific technology, applied in the field of genetic engineering
Inactive Publication Date: 2021-08-06
GUANGDONG TCRCURE BIOPHARMA TECHNOLOGY CO LTD
View PDF1 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, there are no qPCR primers designed for these 15 TCR gene sequences in the prior art, which can monitor the growth and survival of TCR-T cells in patients
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0039] Example 1 Primer Design
[0040] According to HLAA02 typing, L2-1, L2-2, L2-3, L2-5, L2-6, L2-9, L2-10, L2-11, L2-12, Primer pairs were designed for L2-13, L2-16, L2-19, L2-23, L2-24 and L2-25 sites. The obtained primer sequences are shown in SEQ ID NO.1-30.
[0042] Take the L2-1 site of TCR as an example to design the scheme.
[0043] Take 10 of the plasmidDNA standard at the L2-1 site 8 copy number dilution, 10 7 copy number dilution, 10 6 copy number dilution, 10 5 copy number dilution, 10 4 copy number dilution, 10 3 copy number dilution, 10 2 copy number dilution, 10 1 copy number dilutions, and set up real-time fluorescent PCR according to the following reaction system and reaction procedures.
[0045] PCR reaction program: 95°C, 30s; (95°C, 5s; 60°C, 20s) 40 cycles. Set the reference fluorescence to ROX, select the reaction type as SYBR ...
Embodiment 3
[0050] Embodiment 3 Sensitivity detection
[0051] The genomic DNAstock solution, 10-fold dilution, 100-fold dilution, 1000-fold dilution, and 10000-fold dilution of the TCR-T celldrug directed at the L2-1 site, according to the reaction system and program of real-time fluorescent PCR in Example 2 Amplify. The amplification curve of the genomic DNA of the obtained TCR-T cell drug against the L2-1 site is as follows Figure 4 shown. The amplified products were subjected to agarosegel electrophoresis, and the results were as follows: Figure 5 shown.
[0052] Substitute the obtained Ct value of the genomic DNA of each dilution of the TCR-T cell drug into the standard curve in Example 2, and the copy number of the genomic DNA of each dilution of the TCR-T cell drug can be calculated.
[0053] After calculation, the copy number of the TCR-T cell drug genomic DNA stock solution targeting the L2-1 site is 19079 copies, the copy number of the 10-fold dilution is 1721 copies, a...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention belongs to the technical field of geneengineering, and particularly relates to a TCR primer group for specifically recognizing an EBV peptide fragment with immune typing of HLAA02 and application of the TCR primer group. The primer group provided by the invention is designed according to HLAA02 typing and TCR of an EBV virusantigenpeptide fragment FLYALALLL, and comprises one or more of TCR primer pairs with the loci of L2-1, L2-2, L2-3, L2-5, L2-6, L2-9, L2-10, L2-11, L2-12, L2-13, L2-16, L2-19, L2-23, L2-24 and L2-25. The sequences of the primers disclosed by the invention are as shown in SEQ ID NO. 1-30. The primer group disclosed by the invention can be used for specifically recognizing the TCR of the EBV antigenpeptide fragment FLYALALL in the body of an HLAA02 typing patient.
Description
technical field [0001] The invention relates to the technical field of genetic engineering, in particular to a TCR primer set for specifically recognizing EBV virus peptides immunotyped as HLAA02 and its application. Background technique [0002] EBV is a member of the herpesvirus family that can infect humans. EBV infection has been linked to certain types of cancer. These cancer patients caused by EBV virus infection are expected to benefit from TCR-T cell therapy. [0003] TCR-T cell therapy is a promising new generation of immune cell therapy for solid tumors. During TCR-T cell therapy, it is necessary to continuously monitor the growth and persistence of the medicinal TCR-T cells infused into the patient. Among the technical means that can achieve this goal, fluorescent quantitative PCR (qPCR) is a technical means with high detection sensitivity. To monitor TCR-T cells by qPCR, it is necessary to design qPCR primers for the specific TCR gene sequence of TCR-T cells....
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.